Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Varex Imaging CorpVREX · Entity 5135 | SVP and GM, X-Ray Detectors | February 15, 2017 | February 17, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Varex Imaging Corp
Report date February 15, 2017 · Filed February 17, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,290 |
Ending reported balance
After 2017-02-15 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2017-02-15 · Exercise / conversion · Acquired 1,963 · Balance 1,963 F1: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Row 2 · 2017-02-15 · Exercise / conversion · Acquired 1,592 · Balance 3,555 F1: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Row 3 · 2017-02-15 · Exercise / conversion · Acquired 1,767 · Balance 5,322 F1: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Row 4 · 2017-02-15 · Tax withholding · Disposed 2,032 · Balance 3,290 F2: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-02-15 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-02-15 · Exercise / conversion · Disposed 1,963 · Balance 0 F1: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3: These Restricted Stock Units vest February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,592 |
Reported balance
After 2017-02-15 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2017-02-15 · Exercise / conversion · Disposed 1,592 · Balance 1,592 F1: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4: These Restricted Stock Units vest in two equal annual installments beginning February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 3,533 |
Reported balance
After 2017-02-15 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2017-02-15 · Exercise / conversion · Disposed 1,767 · Balance 3,533 F1: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5: These Restricted Stock Units vest in three annual equal installments beginning February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 9,514 |
Reported balance
After 2017-02-16 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2017-02-16 · Grant · Acquired 4,389 · Balance 9,514 F1: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F6: The Restricted Stock Units granted on February 16, 2017 vest 25% each year for four years beginning on February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $31.08 · Expires 2024-02-16 | Direct | 46,466 |
Reported balance
After 2017-02-16 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2017-02-16 · Grant · Acquired 46,466 · Balance 46,466 F7: This Non-Qualified Stock Option is subject to a four-year vesting schedule. 25% of the total number of shares vests one year from grant date, and the remaining 75% vests monthly thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit converts into common stock on a one-for-one basis.
F2: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein.
F3: These Restricted Stock Units vest February 15, 2017. Vested shares will be delivered to the reporting person upon vest date.
F4: These Restricted Stock Units vest in two equal annual installments beginning February 15, 2017. Vested shares will be delivered to the reporting person upon vest date.
F5: These Restricted Stock Units vest in three annual equal installments beginning February 15, 2017. Vested shares will be delivered to the reporting person upon vest date.
F6: The Restricted Stock Units granted on February 16, 2017 vest 25% each year for four years beginning on February 15, 2018. Vested shares will be delivered to the reporting person upon vest date.
F7: This Non-Qualified Stock Option is subject to a four-year vesting schedule. 25% of the total number of shares vests one year from grant date, and the remaining 75% vests monthly thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 16, 2017 Filed Feb 17, 2017 20:33 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 46,466 | $0.00 Strike: $31.08 | $0.00 |
DisclosureSEC source: 0001214659-17-001262 · marketforms-37975.xml · derivative · entry 9 Colbeth Richard E. · CIK 0001695289 · SVP and GM, X-Ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,466 Underlying: Common Stock · 46,466 shares Expires 2024-02-16 F7 · derivative.exercise_date: This Non-Qualified Stock Option is subject to a four-year vesting schedule. 25% of the total number of shares vests one year from grant date, and the remaining 75% vests monthly thereafter. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 20:33 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantRestricted Stock Units · Derivative | 4,389 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-001262 · marketforms-37975.xml · derivative · entry 8 Colbeth Richard E. · CIK 0001695289 · SVP and GM, X-Ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,514 Underlying: Common Stock · 4,389 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F6 · derivative.exercise_date: The Restricted Stock Units granted on February 16, 2017 vest 25% each year for four years beginning on February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. F6 · derivative.expiration_date: The Restricted Stock Units granted on February 16, 2017 vest 25% each year for four years beginning on February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 20:33 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionRestricted Stock Units · Derivative | 1,767 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-001262 · marketforms-37975.xml · derivative · entry 7 Colbeth Richard E. · CIK 0001695289 · SVP and GM, X-Ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,533 Underlying: Common Stock · 1,767 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5 · derivative.exercise_date: These Restricted Stock Units vest in three annual equal installments beginning February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.expiration_date: These Restricted Stock Units vest in three annual equal installments beginning February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 20:33 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionRestricted Stock Units · Derivative | 1,592 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-001262 · marketforms-37975.xml · derivative · entry 6 Colbeth Richard E. · CIK 0001695289 · SVP and GM, X-Ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,592 Underlying: Common Stock · 1,592 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Restricted Stock Units vest in two equal annual installments beginning February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: These Restricted Stock Units vest in two equal annual installments beginning February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 20:33 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionRestricted Stock Units · Derivative | 1,963 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-001262 · marketforms-37975.xml · derivative · entry 5 Colbeth Richard E. · CIK 0001695289 · SVP and GM, X-Ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,963 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Restricted Stock Units vest February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: These Restricted Stock Units vest February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 20:33 UTC | Varex Imaging Corp VREX · Entity 5135 | Tax withholdingCommon Stock | 2,032 | $29.93 | $60,817.76 |
DisclosureSEC source: 0001214659-17-001262 · marketforms-37975.xml · nonDerivative · entry 4 Colbeth Richard E. · CIK 0001695289 · SVP and GM, X-Ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,290 F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 20:33 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 1,767 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-17-001262 · marketforms-37975.xml · nonDerivative · entry 3 Colbeth Richard E. · CIK 0001695289 · SVP and GM, X-Ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,322 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 20:33 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 1,592 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-17-001262 · marketforms-37975.xml · nonDerivative · entry 2 Colbeth Richard E. · CIK 0001695289 · SVP and GM, X-Ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 20:33 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 1,963 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-17-001262 · marketforms-37975.xml · nonDerivative · entry 1 Colbeth Richard E. · CIK 0001695289 · SVP and GM, X-Ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,963 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| January 28, 2017 Filed Jan 31, 2017 21:03 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantRestricted Stock Units · Derivative | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000582 · marketforms-37683.xml · derivative · entry 6 Colbeth Richard E. · CIK 0001695289 · SVP and GM, X-Ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires not disclosed F5 · derivative.exercise_price: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F5 · shares: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F8 · derivative.exercise_date: These RSUs vest in three equal annual installments beginning on February 12, 2017. Vested shares will be delivered to the reporting person upon vest date. F8 · derivative.expiration_date: These RSUs vest in three equal annual installments beginning on February 12, 2017. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.underlying_shares: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F5 · balance_after: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document |
| January 28, 2017 Filed Jan 31, 2017 21:03 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantRestricted Stock Units · Derivative | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000582 · marketforms-37683.xml · derivative · entry 5 Colbeth Richard E. · CIK 0001695289 · SVP and GM, X-Ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires not disclosed F5 · derivative.exercise_price: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F5 · shares: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F7 · derivative.exercise_date: These RSUs vest in two equal annual installments beginning on February 13, 2017. Vested shares will be delivered to the reporting person upon vest date. F7 · derivative.expiration_date: These RSUs vest in two equal annual installments beginning on February 13, 2017. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.underlying_shares: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F5 · balance_after: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document |
| January 28, 2017 Filed Jan 31, 2017 21:03 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantRestricted Stock Units · Derivative | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000582 · marketforms-37683.xml · derivative · entry 4 Colbeth Richard E. · CIK 0001695289 · SVP and GM, X-Ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires not disclosed F5 · derivative.exercise_price: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F5 · shares: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F6 · derivative.exercise_date: These RSUs vest February 21, 2017. Vested shares will be delivered to the reporting person upon vest date. F6 · derivative.expiration_date: These RSUs vest February 21, 2017. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.underlying_shares: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F5 · balance_after: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document |
| January 28, 2017 Filed Jan 31, 2017 21:03 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000582 · marketforms-37683.xml · derivative · entry 3 Colbeth Richard E. · CIK 0001695289 · SVP and GM, X-Ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires 2023-02-12 F1 · derivative.exercise_price: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F4 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 12, 2016 and the remaining vests monthly thereafter. F1 · derivative.underlying_shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · balance_after: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. Read SEC document |
| January 28, 2017 Filed Jan 31, 2017 21:03 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000582 · marketforms-37683.xml · derivative · entry 2 Colbeth Richard E. · CIK 0001695289 · SVP and GM, X-Ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires 2022-02-13 F1 · derivative.exercise_price: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F3 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 13, 2015 and the remaining vests monthly thereafter. F1 · derivative.underlying_shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · balance_after: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. Read SEC document |
| January 28, 2017 Filed Jan 31, 2017 21:03 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000582 · marketforms-37683.xml · derivative · entry 1 Colbeth Richard E. · CIK 0001695289 · SVP and GM, X-Ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires 2021-02-21 F1 · derivative.exercise_price: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F2 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 21, 2014 and the remaining vests monthly thereafter. F1 · derivative.underlying_shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · balance_after: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:03 UTC Amendment | Varex Imaging Corp VREX · Entity 5135 | GrantRestricted Stock Units · Derivative | 5,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000917 · marketforms-37791.xml · derivative · entry 6 Colbeth Richard E. · CIK 0001695289 · SVP and GM, X-Ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,447 Underlying: Common Stock · 5,300 shares Expires 2020-02-15 F5 · derivative.exercise_price: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F5 · shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F8 · derivative.exercise_date: These RSUs vest in three equal annual installments beginning on February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.underlying_shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F5 · balance_after: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:03 UTC Amendment | Varex Imaging Corp VREX · Entity 5135 | GrantRestricted Stock Units · Derivative | 3,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000917 · marketforms-37791.xml · derivative · entry 5 Colbeth Richard E. · CIK 0001695289 · SVP and GM, X-Ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,447 Underlying: Common Stock · 3,184 shares Expires 2019-02-15 F5 · derivative.exercise_price: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F5 · shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F7 · derivative.exercise_date: These RSUs vest in two equal annual installments beginning on February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.underlying_shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F5 · balance_after: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:03 UTC Amendment | Varex Imaging Corp VREX · Entity 5135 | GrantRestricted Stock Units · Derivative | 1,963 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000917 · marketforms-37791.xml · derivative · entry 4 Colbeth Richard E. · CIK 0001695289 · SVP and GM, X-Ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,447 Underlying: Common Stock · 1,963 shares Expires 2018-02-15 F5 · derivative.exercise_price: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F5 · shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F6 · derivative.exercise_date: These RSUs vest February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.underlying_shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F5 · balance_after: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:03 UTC Amendment | Varex Imaging Corp VREX · Entity 5135 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 14,703 | $0.00 Strike: $25.17 | $0.00 |
DisclosureSEC source: 0001214659-17-000917 · marketforms-37791.xml · derivative · entry 3 Colbeth Richard E. · CIK 0001695289 · SVP and GM, X-Ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,703 Underlying: Common Stock · 14,703 shares Expires 2023-02-12 F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F4 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 12, 2016 and the remaining vests monthly thereafter. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:03 UTC Amendment | Varex Imaging Corp VREX · Entity 5135 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 11,932 | $0.00 Strike: $30.74 | $0.00 |
DisclosureSEC source: 0001214659-17-000917 · marketforms-37791.xml · derivative · entry 2 Colbeth Richard E. · CIK 0001695289 · SVP and GM, X-Ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,932 Underlying: Common Stock · 11,932 shares Expires 2022-02-13 F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F3 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 13, 2015 and the remaining vests monthly thereafter. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:03 UTC Amendment | Varex Imaging Corp VREX · Entity 5135 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 13,515 | $0.00 Strike: $27.77 | $0.00 |
DisclosureSEC source: 0001214659-17-000917 · marketforms-37791.xml · derivative · entry 1 Colbeth Richard E. · CIK 0001695289 · SVP and GM, X-Ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,515 Underlying: Common Stock · 13,515 shares Expires 2021-02-21 F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F2 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 21, 2014 and the remaining vests monthly thereafter. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.